MedTrace Logo

Vaginal Laser Therapy in Breast Cancer Survivors

NCT03738605 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-30

No results posted yet for this study

Summary

This study evaluates the efficacy of vaginal CO2 laser therapy in breast cancer survivors with symptoms of Genitourinary Syndrome of Menopause. Half of participants will receive active laser therapy, while the other half placebo therapy.

Conditions

  • Genitourinary Syndrome of Menopause
  • Vaginal Atrophy
  • Breast Cancer
  • Dyspareunia

Interventions

DEVICE

Microablative Fractional CO2 Laser Therapy

5 laser therapies intravaginally administered will be applied at monthly intervals.

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Stavros Athanasiou, Associate Proffesor · National and Kapodistrian University of Athens, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-06-30
Completion
2020-08-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03738605 on ClinicalTrials.gov